Coronary Artery Disease

Cardiovascular
125
Pipeline Programs
30
Companies
50
Clinical Trials
1 recruiting
18
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
10
6
16
5
27
61
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Monoclonal Antibody
467%
Peptide
117%
Small Molecule
117%
+ 265 programs with unclassified modality

On Market (18)

Approved therapies currently available

U
ASPRUZYO SPRINKLEApproved
ranolazine
Unknown Company
Anti-anginal [EPC]oral2022
U
CORTANApproved
prednisone
Unknown Company
oral
U
DURLAZAApproved
aspirin
Unknown Company
oral2015
U
IODIXANOLApproved
iodixanol
Unknown Company
Radiographic Contrast Agent [EPC]injection2022
Astellas
LEXISCANApproved
regadenoson
Astellas
Adenosine Receptor Agonist [EPC]intravenous2008
U
LIQUID PREDApproved
prednisone
Unknown Company
oral1982
U
ORASONEApproved
prednisone
Unknown Company
oral1974
U
PRASUGREL HYDROCHLORIDEApproved
prasugrel
Unknown Company
oral2023
U
PREDNICEN-MApproved
prednisone
Unknown Company
oral1975
U
PREDNISONEApproved
prednisone
Unknown Company
oral1975
U
RANOLAZINEApproved
ranolazine
Unknown Company
Anti-anginal [EPC]oral2020
U
REGADENOSONApproved
regadenoson
Unknown Company
intravenous2024
U
REOPROApproved
abciximab
Unknown Company
injection1994
Amgen
REPATHAApproved
evolocumab
Amgen
PCSK9 Inhibitor [EPC]injection2015
U
TIROFIBAN HYDROCHLORIDEApproved
tirofiban
Unknown Company
intravenous2023
U
VAZALOREApproved
aspirin
Unknown Company
oral2013
U
VISIPAQUE 270Approved
iodixanol
Unknown Company
Radiographic Contrast Agent [EPC]injection1996
U
VISIPAQUE 320Approved
iodixanol
Unknown Company
Radiographic Contrast Agent [EPC]injection1997

Competitive Landscape

49 companies ranked by most advanced pipeline stage

C
CordisFL - Miami Lakes
44 programs
5
4
2
13
16
Aspirin and clopidogrel / PrasugrelPhase 41 trial
Bx Cypher stentPhase 41 trial
CYPHER Sirolimus-eluting stentPhase 41 trial
CYPHER sirolimus-eluting stentPhase 41 trial
CYPHERTM Sirolimus-Eluting Coronary StentPhase 41 trial
+39 more programs
Active Trials
NCT00715884Unknown678Est. Sep 2014
NCT01106378Terminated14,000Est. Dec 2011
NCT05946629Recruiting960Est. Jun 2031
+39 more trials
Biotronik
BiotronikGermany - Berlin
39 programs
1
1
1
Percutaneous coronary interventionPhase 41 trial
Hybrid sirolimus- and everolimus-eluting stentsPhase 31 trial
ORSIRO - Drug Eluting Coronary StentPhase 1/21 trial
Abbott Laboratories XienceN/A1 trial
BIOFLOW III Asia Registry Orsiro Stent SystemN/A1 trial
+34 more programs
Active Trials
NCT01939249Unknown585Est. Jan 2020
NCT01941290Completed387Est. Apr 2017
NCT02029092Completed404Est. Jul 2016
+36 more trials
Abbott
AbbottABBOTT PARK, IL
37 programs
1
2
4
ABSORB implantationPhase 41 trial
Guidant GALILEO Intravascular Radiotherapy SystemPhase 41 trial
Inhalational anestheticPhase 41 trial
Multi-Link Frontier Coronary Stent SystemPhase 41 trial
ABT-335Phase 32 trials
+32 more programs
Active Trials
NCT01685047Completed481Est. Apr 2016
NCT04282148Completed107Est. Sep 2023
NCT01425281Completed501Est. May 2018
+45 more trials
HeartFlow
14 programs
1
EvolocumabPhase 4Monoclonal Antibody
AI-enabled quantitative coronary plaque analysisN/A1 trial
Assessing Diagnostic Value of Non-invasive FFRCT in Coronary CareN/A1 trial
CMR and CTCA with CT-FFRN/A1 trial
Coronary computed tomography angiographyN/A1 trial
+9 more programs
Active Trials
NCT06376851Active Not Recruiting20,000Est. Mar 2030
NCT02499679Completed4,737Est. May 2019
NCT04761991RecruitingEst. Nov 2025
+10 more trials
OrbusNeich
10 programs
1
1
1
Coronary stent implantationPhase 41 trial
Genous stent implantation with paclitaxel-eluting balloon dilationPhase 2/31 trial
PTCA with stent placementPhase 21 trial
Deutsches Dual Therapy Stent RegisterN/A1 trial
Evaluation of Effectiveness and Safety of the GENOUS STENT (IRIS-GENOUS STEMI)N/A1 trial
+5 more programs
Active Trials
NCT02102997Terminated130Est. Nov 2017
NCT01348373Completed464Est. Jun 2014
NCT02183454Completed2,500Est. May 2017
+7 more trials
GS
Gilead SciencesFOSTER CITY, CA
8 programs
1
3
2
RanolazinePhase 4
RanolazinePhase 41 trial
RanolazinePhase 31 trial
RanolazinePhase 3
RegadenosonPhase 31 trial
+3 more programs
Active Trials
NCT02272062Completed203Est. Jun 2016
NCT00738049Completed40Est. Aug 2011
NCT01442038Completed2,651Est. Feb 2015
+2 more trials
Bayer
8 programs
1
1
240 mg IodinePhase 41 trial
VericiguatPhase 1
Diagnostic detection of coronary artery diseaseN/A1 trial
Dual Source CT Angiography for Detection of Coronary Artery StenosesN/A1 trial
MR perfusion guidanceN/A1 trial
+3 more programs
Active Trials
NCT02810795Completed180Est. Dec 2020
NCT01190579Unknown398Est. Dec 2010
NCT01236807Completed915Est. Dec 2016
+4 more trials
Astellas
AstellasChina - Shenyang
8 programs
1
1
1
Regadenoson; OptisonPhase 31 trial
adenosinePhase 13 trials
Dual Source Multidetector CTN/A1 trial
FFR Measurement with IV Adenoscan® then with RegadenosonN/A1 trial
Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital SettingN/A1 trial
+3 more programs
Active Trials
NCT00892307Completed34Est. May 2011
NCT01482169Completed48Est. Sep 2014
NCT02756234Completed19Est. Aug 2018
+11 more trials
DS
8 programs
2
1
4
AtorvastatinPhase 4Small Molecule
PrasugrelPhase 41 trial
PrasugrelPhase 41 trial
Prasugrel Loading DosePhase 41 trial
PrasugrelPhase 21 trial
+3 more programs
Active Trials
NCT00997503Completed4,199Est. Jul 2015
NCT01107925Completed72Est. Aug 2011
NCT01107912Completed155Est. Oct 2011
+4 more trials
LB
Lepu BiopharmaChina - Shanghai
7 programs
1
2
Clopidogrel and aspirin dual-antiplatelet therapyPhase 41 trial
Nano+ DESPhase 41 trial
NeoVas BCSPhase 11 trial
DCB of Lepu MedicalN/A1 trial
Drug-Coated BalloonN/A1 trial
+2 more programs
Active Trials
NCT04953117UnknownEst. Apr 2023
NCT05101005UnknownEst. Nov 2023
NCT02305472UnknownEst. Sep 2020
+4 more trials
Lantheus Medical Imaging
1
2
1
Perflutren Lipid Microsphere Injectable SuspensionPhase 41 trial
Flurpiridaz F18Phase 31 trial
Flurpiridaz F18Phase 31 trial
[3H] BMS747158Phase 11 trial
Echocardiography: Value and Accuracy at REst and STressN/A1 trial
+2 more programs
Active Trials
NCT03674255Enrolling By Invitation23,000Est. Jan 2032
NCT01436773CompletedEst. May 2012
NCT00930631CompletedEst. Jan 2010
+3 more trials
Rhythm Pharmaceuticals
6 programs
1
Medtronic Endeavor ResolutePhase 41 trial
Endeavor Resolute StentN/A1 trial
Endeavor Resolute Zotarolimus-Eluting Coronary Stent SystemN/A1 trial
Endeavor Zotarolimus Eluting Coronary StentN/A1 trial
ICDN/A1 trial
+1 more programs
Active Trials
NCT00850213Completed448Est. Feb 2011
NCT00752128CompletedEst. Dec 2012
NCT00623441Completed8,314Est. Feb 2009
+3 more trials
J&
Johnson & JohnsonNEW BRUNSWICK, NJ
4 programs
1
2
Coronary placement of bare metal stent vs. drug eluting stentPhase 41 trial
Percutaneous coronary interventionPhase 41 trial
Endoscopic Radial Artery HarvestPhase 2/31 trial
Percutaneous coronary interventionN/A1 trial
Active Trials
NCT00914199Completed477Est. Nov 2021
NCT00303706Completed119Est. Aug 2007
NCT00220558Unknown150Est. Feb 2010
+1 more trials
Sanofi
3 programs
1
RAMIPRIL HOE498Phase 41 trial
Coronary Artery Disease and Renal Failure RegistryN/A
Genotype Information and Functional Testing StudyN/A1 trial
Active Trials
NCT00992420Completed2,000Est. Aug 2010
NCT03099213Completed179Est. Apr 2010
Bristol Myers Squibb
3 programs
1
1
AbciximabPhase 4Monoclonal Antibody
AspirinPhase 32 trials
Genotype Information and Functional Testing StudyN/A
Active Trials
NCT05093790Completed58Est. Nov 2022
NCT00330772Completed150Est. Dec 2008
Boehringer Ingelheim
Boehringer IngelheimINGELHEIM, Germany
2 programs
1
Dabigatran + TicagrelorPhase 41 trial
Coronary Artery Disease and Renal Failure RegistryN/A1 trial
Active Trials
NCT00679419Unknown3,352Est. May 2013
NCT04688723Unknown1,000Est. Jul 2023
Amgen
2 programs
1
EvolocumabPhase 4Monoclonal Antibody1 trial
Coronary Artery Disease and Renal Failure RegistryN/A
Active Trials
NCT03851263Withdrawn0Est. Feb 2023
M&
Merck & Co.RAHWAY, NJ
2 programs
1
TirofibanPhase 41 trial
Determination of plasma GLP-1 levelN/A1 trial
Active Trials
NCT02280837Completed190Est. Dec 2020
NCT00407771Unknown44Est. Dec 2008
Guerbet
2 programs
2
IodixanolPhase 41 trial
iobitridolPhase 41 trial
Active Trials
NCT01848899Completed100Est. Nov 2014
NCT01255722Completed468Est. Sep 2012
Novo Nordisk
2 programs
1
ZiltivekimabPhase 3Monoclonal Antibody1 trial
Characterization of Epicardial and Pericardial Adipose Tissue in Coronary Artery DiseaseN/A1 trial
Active Trials
NCT02965625Completed28Est. Jun 2018
NCT07276282Not Yet Recruiting332Est. Dec 2028
Pfizer
2 programs
2
binodenosonPhase 31 trial
binodenosonPhase 31 trial
Active Trials
NCT00944294Completed419Est. Apr 2006
NCT00944970Completed578Est. Dec 2006
Beacon Therapeutics
1
Perfusion CMR for detection of coronary artery diseasePhase 31 trial
Active Trials
NCT00977093CompletedEst. Jun 2004
Verona Pharma
4 programs
1
PrednisonePhase 2/31 trial
ABCDE-Stress EchoN/A
Coronary physiology assessment using Fractional Flow ReserveN/A1 trial
Physiologically-guided strategyN/A1 trial
Active Trials
NCT07186582Active Not Recruiting1,000Est. Dec 2034
NCT03360591Active Not Recruiting320Est. Jun 2025
NCT00369356Completed375Est. Jan 2011
AstraZeneca
7 programs
2
2
TicagrelorPhase 21 trial
Ticagrelor TabletsPhase 21 trial
Form 1 of AZD5718 tabletsPhase 11 trial
Treatment APhase 11 trial
Coronary Artery Disease and Renal Failure RegistryN/A
+2 more programs
Active Trials
NCT01054365Completed100Est. May 2013
NCT03420092Completed14Est. Apr 2018
NCT04087187Completed14Est. Oct 2019
+2 more trials
Stereotaxis
2 programs
1
PowerAssert RF wire in crossing coronary in-stent chronic total occlusionsPhase 21 trial
Percutaneous coronary interventionN/A1 trial
Active Trials
NCT00994331Terminated4Est. Mar 2011
NCT01131793Completed5Est. Mar 2011
E
2 programs
2
E5555Phase 21 trial
E5555 50 mgPhase 21 trial
Active Trials
NCT00312052Completed720Est. Aug 2009
NCT00540670Completed240
R
2 programs
2
RVX000222Phase 21 trial
RVX000222Phase 21 trial
Active Trials
NCT01423188Completed176Est. Aug 2012
NCT01067820Completed324Est. Jun 2013
BioMarin Pharmaceutical
1
6R-BH4Phase 21 trial
Active Trials
NCT00423280Unknown66Est. Feb 2009
Knight Therapeutics
Knight TherapeuticsQC - Montréal
1 program
1
ExparelPhase 21 trial
Active Trials
NCT01826851Completed79Est. Jun 2017
Eli Lilly and Company
Eli Lilly and CompanyINDIANAPOLIS, IN
1 program
1
prasugrelPhase 1

+19 more companies

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Boehringer IngelheimDabigatran + Ticagrelor
Lepu BiopharmaClopidogrel and aspirin dual-antiplatelet therapy
BiotronikPercutaneous coronary intervention
AmgenEvolocumab
AstellasRegadenoson
AstellasRegadenoson
Bayer240 mg Iodine
AbbottABSORB implantation
Lepu BiopharmaNano+ DES
GuerbetIodixanol
AstellasRegadenoson
Daiichi SankyoPrasugrel Loading Dose
AstellasRegadenoson
AbbottXience
Guerbetiobitridol

Showing 15 of 50 trials with date data

Clinical Trials (50)

Total enrollment: 46,237 patients across 50 trials

NCT04688723Boehringer IngelheimDabigatran + Ticagrelor

Dual Therapy With Dabigatran/Ticagrelor Versus Dual Therapy With Dabigatran/Clopidogrel in ACS Patients With Indication for NOAC Undergoing PCI

Start: Dec 2020Est. completion: Jul 20231,000 patients
Phase 4Unknown
NCT04624854Lepu BiopharmaClopidogrel and aspirin dual-antiplatelet therapy

Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Start: Oct 2020Est. completion: Sep 2025
Phase 4Completed
NCT04137510BiotronikPercutaneous coronary intervention

Bioflow-DAPT Study

Start: Feb 2020Est. completion: Sep 20221,948 patients
Phase 4Completed

Multislice Computed Tomography Assessment of PCSK9 Inhibition on Coronary Perfusion

Start: Aug 2019Est. completion: Feb 20230
Phase 4Withdrawn

Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction

Start: Nov 2015Est. completion: Jun 201614 patients
Phase 4Completed

Accuracy of an Echo-Stress Protocol Using Regadenoson With Speckle Tracking

Start: Sep 2014Est. completion: Jun 2024
Phase 4Completed
NCT02462044Bayer240 mg Iodine

Contrast Enhancement on Coronary Computed Tomographic Angiography

Start: Aug 2014Est. completion: Sep 2015200 patients
Phase 4Completed
NCT02004730AbbottABSORB implantation

Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears

Start: Dec 2013Est. completion: Jun 20151,000 patients
Phase 4Unknown

Efficacy and Safety of Nano+ Polymer-free Sirolimus-Eluting Stent: A Optical Coherent Tomography Study

Start: Jul 2013Est. completion: Nov 2016
Phase 4Unknown

Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography

Start: Feb 2013Est. completion: Nov 2014100 patients
Phase 4Completed

Development of a PET-MR Myocardial Perfusion Examination Using Regadenoson

Start: Jan 2013Est. completion: Jun 201516 patients
Phase 4Completed
NCT01587651Daiichi SankyoPrasugrel Loading Dose

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

Start: Mar 2012Est. completion: Feb 2013110 patients
Phase 4Completed

Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease

Start: Aug 2011Est. completion: Jun 201850 patients
Phase 4Unknown

Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTing Using the PRIME Platform (EXCELLENT-PRIME Registry)

Start: May 2011Est. completion: Apr 20152,000 patients
Phase 4Unknown

Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography

Start: Nov 2010Est. completion: Sep 2012468 patients
Phase 4Completed

The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease

Start: Nov 2010Est. completion: Sep 2011110 patients
Phase 4Completed

Prasugrel/Clopidogrel Maintenance Dose Washout Study

Start: Feb 2010Est. completion: Jun 201056 patients
Phase 4Completed
NCT01239953Abbotteverolimus-eluting stent

RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)

Start: Jan 2010190 patients
Phase 4Unknown
NCT00954707CordisClopidogrel & Aspirin, Prasugrel & Aspirin

CYPRESS - CYPHER for Evaluating Sustained Safety

Start: Aug 2009Est. completion: Mar 20162,509 patients
Phase 4Unknown

Stress Testing and Cardiac Magnetic Resonance

Start: Apr 2009Est. completion: Jun 201420 patients
Phase 4Completed

Study of Ranexa in Patients With Coronary Artery Disease and Painful Polyneuropathy

Start: Jan 2009Est. completion: Jun 20095 patients
Phase 4Terminated
NCT00827411CordisAspirin and clopidogrel / Prasugrel

Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy

Start: Jan 2009Est. completion: Jan 20132,500 patients
Phase 4Completed
NCT03099213SanofiRAMIPRIL HOE498

An Open-label, Non-comparative Study to Document the Tolerability to Ramipril in Patients With at Least One High Risk for Developing a Major Cardiovascular Event

Start: Nov 2008Est. completion: Apr 2010179 patients
Phase 4Completed
NCT00698607Abbotteverolimus-eluting stent

Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing

Start: Jun 2008Est. completion: Apr 20141,466 patients
Phase 4Unknown
NCT00617084Rhythm PharmaceuticalsMedtronic Endeavor Resolute

Randomized, Two-arm, Non-inferiority Study Comparing Endeavor-Resolute Stent With Abbot Xience-V Stent

Start: Apr 2008Est. completion: Feb 2014
Phase 4Completed

The Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention

Start: Nov 2007Est. completion: Dec 200844 patients
Phase 4Unknown
NCT00349895OrbusNeichCoronary stent implantation

Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth

Start: Aug 2006Est. completion: Jan 2012100 patients
Phase 4Completed
NCT00855478CordisCypher stent ™ or Cypher Select ™

French Post-Marketing Surveillance Survey

Start: May 2006Est. completion: Sep 20084,080 patients
Phase 4Terminated
NCT00438919Cordisdrug-eluting stent

A Multi-center Post-Market Surveillance Registry

Start: May 2006Est. completion: Dec 200915,000 patients
Phase 4Completed
NCT00323895Cordisdrug-eluting stent and balloon angioplasty

The Intra-Drug Eluting Stent (DES) Restenosis Study

Start: Mar 2006Est. completion: Jan 2010320 patients
Phase 4Completed
NCT00286585AbbottInhalational anesthetic

TEAM-Project: Trial on the Effect of Anesthetics on Morbidity and Mortality

Start: Feb 2006Est. completion: Nov 2011385 patients
Phase 4Completed
NCT00292305CordisPercutaneous coronary intervention

Nordic Bifurcation Stent Technique Study (BIF II)

Start: Sep 2005Est. completion: Dec 2012425 patients
Phase 4Completed
NCT00220558Johnson & JohnsonCoronary placement of bare metal stent vs. drug eluting stent

GISSOC II: Sirolimus Eluting Stent Versus Bare Metal Stent in Chronic Total Coronary Occlusions

Start: May 2005Est. completion: Feb 2010150 patients
Phase 4Unknown
NCT00286195AbbottMulti-Link Frontier Coronary Stent System

Frontier Registry II Bifurcation Stent System Registry

Start: Dec 2004Est. completion: Dec 20060
Phase 4Withdrawn
NCT00376571Johnson & JohnsonPercutaneous coronary intervention

Nordic Bifurcation Study. How to Use Drug Eluting Stents (DES) in Bifurcation Lesions?

Start: Oct 2004Est. completion: Mar 2011413 patients
Phase 4Completed
NCT00162370Lantheus Medical ImagingPerflutren Lipid Microsphere Injectable Suspension

A Study of Stress Echocardiography in Post-Menopausal Women at Risk for Coronary Disease

Start: Apr 2004Est. completion: Oct 2012
Phase 4Completed

The Study of the Crushing Technique Application Using SES in Coronary Bifurcations.

Start: Jan 2004Est. completion: Apr 2009350 patients
Phase 4Completed
NCT00497172CordisCYPHER Sirolimus-eluting stent

Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial

Start: Jan 2004Est. completion: Apr 2009150 patients
Phase 4Completed
NCT00235092CordisCypher Sirolimus-Eluting Stent

The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus

Start: Aug 2003Est. completion: Mar 20061,335 patients
Phase 4Completed
NCT00245401CordisCYPHERTM Sirolimus-Eluting Coronary Stent

CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)

Start: Aug 2003Est. completion: Dec 20042,070 patients
Phase 4Completed
NCT00232856Cordisdrug-eluting stent

A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.

Start: Dec 2002Est. completion: Aug 2006162 patients
Phase 4Completed

The CYPHER™ Stent Study in Patients With Small de Novo Coronary Artery Lesions.

Start: Nov 2002Est. completion: Apr 2006100 patients
Phase 4Completed
NCT00495898CordisCYPHER sirolimus-eluting stent

A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions

Start: Nov 2002Est. completion: Nov 2009200 patients
Phase 4Completed
NCT00232804CordisBx Cypher stent

The BRIDGE Registry: Safety and Efficacy Registry of Bx Cypher Stent

Start: Jun 2002Est. completion: Feb 2004639 patients
Phase 4Completed
NCT00180583AbbottGuidant GALILEO Intravascular Radiotherapy System

Vision II: Evaluation of GALILEO Intravascular Radiotherapy System

Start: Feb 2002Est. completion: Jul 2005268 patients
Phase 4Completed

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

Start: Mar 2026Est. completion: May 2027250 patients
Phase 3Not Yet Recruiting

Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction

Start: Dec 2025Est. completion: Dec 2028332 patients
Phase 3Not Yet Recruiting

Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE

Start: Sep 2024Est. completion: Mar 20291,746 patients
Phase 3Not Yet Recruiting

Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program

Start: Apr 2022Est. completion: Aug 2028600 patients
Phase 3Recruiting

Breast Cancer WEight Loss Study (BWEL Study)

Start: Sep 2016Est. completion: May 20303,177 patients
Phase 3Active Not Recruiting

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

27 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials targeting 46,237 patients
30 companies competing in this space